Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 14, 2020

SELL
$0.48 - $1.67 $7,056 - $24,549
-14,700 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$0.28 - $1.23 $4,116 - $18,081
14,700 New
14,700 $10,000
Q3 2018

Nov 14, 2018

SELL
$5.36 - $7.83 $5.12 Million - $7.48 Million
-954,881 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$5.97 - $9.58 $4.94 Million - $7.93 Million
-827,883 Reduced 46.44%
954,881 $7.39 Million
Q1 2018

May 15, 2018

SELL
$4.21 - $7.0 $3.94 Million - $6.55 Million
-935,542 Reduced 34.42%
1,782,764 $11.6 Million
Q4 2017

Feb 14, 2018

SELL
$3.73 - $4.6 $1.75 Million - $2.16 Million
-470,233 Reduced 14.75%
2,718,306 $11.2 Million
Q3 2017

Nov 14, 2017

BUY
$3.9 - $6.78 $12.4 Million - $21.6 Million
3,188,539
3,188,539 $13.4 Million

About T2 Biosystems, Inc.


  • Ticker TTOO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 7,050,850
  • Market Cap $3.38M
  • Description
  • T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...
More about TTOO
Track This Portfolio

Track Lagoda Investment Management, L.P. Portfolio

Follow Lagoda Investment Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lagoda Investment Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Lagoda Investment Management, L.P. with notifications on news.